ArticleFrontiers in immunology2021

Adenovirus Armed With TNFa and IL2 Added to aPD-1 Regimen Mediates Antitumor Efficacy in Tumors Refractory to aPD-1.

Victor Cervera-Carrascon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.